Drug Facts
Active ingredient
Olopatadine (0.2%)
(equivalent to olopatadine hydrochloride, USP 0.222%)
The following Structured Product Label (SPL) was submitted to the FDA by Walgreen Co. for the product Olopatadine Hydrochloride (NDC 0363-8022). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding drug facts, purpose, use, warnings, do not use, when using this product, stop use and ask a doctor if you experience:, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Active ingredient
Olopatadine (0.2%)
(equivalent to olopatadine hydrochloride, USP 0.222%)
Antihistamine
temporarily relieves itchy eyes due to pollen, ragweed, grass, animal hair and dander
For external use only
If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.
consult a doctor
benzalkonium chloride 0.01%, dibasic sodium phosphate, edetate disodium, hydrochloric acid/sodium hydroxide (adjust pH), povidone, sodium chloride and water for injection
✆1-800-925-4733
Distributed by:
WALGREEN CO.
200 WILMOT RD., DEERFIELD, IL 60015
Made in India
ORIGINAL PRESCRIPTION STRENGTH
NDC 0363-8022-39
Walgreens
Compare to the active ingredient in
Pataday® Once Daily Relief‡‡
Eye Allergy
Itch Relief
OLOPATADINE HYDROCHLORIDE
OPHTHALMIC SOLUTION USP, 0.2%
ANTIHISTAMINE
Once Daily
• Works in minutes
• Relief from allergens:
pet dander, grass,
pollen & ragweed
• Sterile
2.5 mL (0.085 FL OZ)
TWIN PACK
ORINIGAL PRESCRIPTION STRENGTH
NDC 0363-8022-41
Walgreens
Compare to the active ingredient in
Pataday® Once Daily Relief‡‡
Eye Allergy
Itch Relief
OLOPATADINE HYDROCHLORIDE
OPHTHALMIC SOLUTION USP, 0.2%
ANTIHISTAMINE
Once Daily
• Works in minutes
• Relief from allergens:
pet dander, grass,
pollen & ragweed
• Sterile
TWO 2.5 mL BOTTLES
(0.085 FL OZ each)
* Please review the disclaimer below.